Viewing Study NCT00001758


Ignite Creation Date: 2025-12-25 @ 12:02 AM
Ignite Modification Date: 2026-01-04 @ 4:57 AM
Study NCT ID: NCT00001758
Status: COMPLETED
Last Update Posted: 2008-03-04
First Post: 1999-11-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Continued Antiretroviral Therapy With Abacavir, Amprenavir and Efavirenz
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module